Differences in Treatment Response in Bronchial Epithelial Cells from Idiopathic Pulmonary Fibrosis (IPF) Patients: A First Step towards Personalized Medicine?

Idiopathic pulmonary fibrosis (IPF) has a detrimental prognosis despite antifibrotic therapies to which individual responses vary. IPF pathology is associated with oxidative stress, inflammation and increased activation of SRC family kinases (SFK). This pilot study evaluates individual responses to...

Descripción completa

Detalles Bibliográficos
Autores principales: Veith, C., Schneider, M. A., Maas, L., van der Vliet, A., van Schooten, F. J., Kreuter, M., Meister, M., Boots, A. W., Kahn, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952618/
https://www.ncbi.nlm.nih.gov/pubmed/36830000
http://dx.doi.org/10.3390/antiox12020443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952618/
https://www.ncbi.nlm.nih.gov/pubmed/36830000
http://dx.doi.org/10.3390/antiox12020443

Ejemplares similares